Search Results 181-190 of 16189 for pharmacogenetics
The Ackerman Sudden Death Genomics Lab at Mayo Clinic is studying cardiac channelopathies related to long QT syndrome and catecholaminergic polymorphic ...
Global collaboration is needed to make sure that a new type of genetic test, the polygenic risk score, performs equitably among people from diverse groups.
Pegfilgrastim-jmdb injection is used to treat neutropenia (low white blood cells) that is caused by cancer medicines. It is a synthetic (man-made) form of a ...
We recognize the transformative power of these tools and are committed to using every resource at our disposal to bring individualized medicine to our patients.
Genetic testing can be performed in utero, but there is risk to the pregnancy and the fetus. Although some fetuses present with arrhythmias easily recognized as ...
The primary purpose of this study is to demonstrate the effectiveness of 1 or 2 dose levels of HZN-825 versus placebo in subjects with diffuse cutaneous ...
Gene expression can amplify the risk of neurodegenerative diseases for patients, but researchers are still figuring out which genes have an outsized effect ...
Learn how genetic testing can help customize your cancer treatment plan. Precision medicine is improving breast cancer diagnosis, treatment and prevention.
About this study. The purpose of this study is to characterize healthcare provider experiences caring for Latino/a patients receiving PRS in a Federally ...
About this study. The purpose of this study is to identify DNA mutations that significantly correlate with arthrofibrosis development after total knee ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.